![Peter van Vlasselaer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter van Vlasselaer
Président chez
Amphivena Therapeutics, Inc.
Profil
Peter van Vlasselaer was the founder of Arresto BioSciences, Inc., founded in 2007, where the title held was President & Chief Executive Officer from 2007 to 2011.
Dr. van Vlasselaer was the founder of ARMO BioSciences, Inc., founded in 2010, where the titles held were President, Chief Executive Officer & Director from 2012 to 2018.
Dr. van Vlasselaer was also the founder of ACIR Biosciences, Inc.,True North Therapeutics, Inc...
Dr. van Vlasselaer was Independent Executive Chairman at Amphivena Therapeutics, Inc. since 2019.
Dr. van Vlasselaer is Director at Inspirna, Inc. since 2018.
Dr. van Vlasselaer is Venture Partner at GSK Equity Investments Ltd since 2021.
Dr. van Vlasselaer is Venture Partner at NanoDimension Management Ltd. since 2019.
Dr. van Vlasselaer is Venture Partner at SR One Capital Management LP since 2021.
Dr. van Vlasselaer was President & Chief Executive Officer at Avidia, Inc. from 2004 to 2006.
Dr. van Vlasselaer was Executive Chairman at Redwood Bioscience, Inc. Dr. van Vlasselaer was Executive Chairman at iPierian, Inc. Dr. van Vlasselaer was Chairman at Asceneuron SA from 2019 to 2023.
Dr. van Vlasselaer was Independent Chairman at Comet Therapeutics, Inc. from 2017 to 2020.
Dr. van Vlasselaer was Director at Blade Therapeutics, Inc. Dr. van Vlasselaer was Senior Vice President-Technical Operations at InterMune, Inc. in 2004.
Dr. van Vlasselaer was Vice President-Drug Development at Dendreon Corp.
from 1993 to 1999.
Dr. van Vlasselaer completed undergraduate and doctorate degrees at Université Catholique de Louvain.
Dr. van Vlasselaer earned a doctorate degree from Stanford University in 1988.
Postes actifs de Peter van Vlasselaer
| Sociétés | Poste | Début |
|---|---|---|
Inspirna, Inc.
 Inspirna, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for cancer | Directeur/Membre du Conseil | 27/11/2018 |
Amphivena Therapeutics, Inc.
 Amphivena Therapeutics, Inc. Drugstore ChainsRetail Trade Provides drug discovery services | Président | 05/03/2019 |
GSK Equity Investments Ltd.
 GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity invests in companies located in the United States and United kingdom. The firm targets companies operating in the field of biotechnology sector. It provides financing for early stage capital requirements. | Private Equity Investor | 11/02/2021 |
NanoDimension Management Ltd.
 NanoDimension Management Ltd. Investment ManagersFinance NanoDimension Management invests in companies located in the United States and Europe. The firm focuses on the technology sector. It provides for early and later stage companies. | Private Equity Investor | 01/07/2019 |
SR One Capital Management LP
 SR One Capital Management LP Investment ManagersFinance SR One invests in companies located in the United States and the United kingdom. The firm focuses on the biotechnology sector. It provides financing for early stage capital requirements. | Private Equity Investor | 01/02/2021 |
Anciens postes connus de Peter van Vlasselaer
| Sociétés | Poste | Fin |
|---|---|---|
Asceneuron SA
 Asceneuron SA BiotechnologyHealth Technology Develops therapeutics for neurodegenerative disorders | Président | 18/12/2023 |
Comet Therapeutics, Inc.
 Comet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes treatments for patients suffering from metabolic, neurological and immunological disorders | Président | 01/09/2020 |
| ARMO BIOSCIENCES INC | Fondateur | 21/06/2018 |
True North Therapeutics, Inc.
 True North Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapies that selectively inhibit the complement system to treat rare diseases | Fondateur | 01/05/2017 |
| ░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Peter van Vlasselaer
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
71
Relations au 1er degré
18
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 18 |
|---|---|
InterMune, Inc.
 InterMune, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that researches and develops therapies in pulmonology & orphan fibrotic diseases | Health Technology |
Dendreon Corp.
 Dendreon Corp. Medical SpecialtiesHealth Technology Discovers, develops and commercializes novel products for the treatment of cancer | Health Technology |
Avidia, Inc.
 Avidia, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Redwood Bioscience, Inc.
 Redwood Bioscience, Inc. BiotechnologyHealth Technology Develops precision protein-chemical engineering technology | Health Technology |
GSK Equity Investments Ltd.
GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity invests in companies located in the United States and United kingdom. The firm targets companies operating in the field of biotechnology sector. It provides financing for early stage capital requirements. | Finance |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NanoDimension Management Ltd.
NanoDimension Management Ltd. Investment ManagersFinance NanoDimension Management invests in companies located in the United States and Europe. The firm focuses on the technology sector. It provides for early and later stage companies. | Finance |
Université Catholique de Louvain
 Université Catholique de Louvain Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arresto BioSciences, Inc.
 Arresto BioSciences, Inc. Miscellaneous Commercial ServicesCommercial Services Develops medicines to treat cancer and fibrotic diseases | Commercial Services |
iPierian, Inc.
 iPierian, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures biopharmaceutical products | Health Technology |
Asceneuron SA
Asceneuron SA BiotechnologyHealth Technology Develops therapeutics for neurodegenerative disorders | Health Technology |
Amphivena Therapeutics, Inc.
Amphivena Therapeutics, Inc. Drugstore ChainsRetail Trade Provides drug discovery services | Retail Trade |
ARMO BioSciences, Inc.
 ARMO BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapy for treatment of cancer | Health Technology |
True North Therapeutics, Inc.
True North Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapies that selectively inhibit the complement system to treat rare diseases | Health Technology |
Inspirna, Inc.
Inspirna, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for cancer | Health Technology |
Blade Therapeutics, Inc.
 Blade Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that focuses on developing treatments for fibrotic and neurodegenerative diseases | Health Technology |
Comet Therapeutics, Inc.
Comet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes treatments for patients suffering from metabolic, neurological and immunological disorders | Health Technology |
SR One Capital Management LP
SR One Capital Management LP Investment ManagersFinance SR One invests in companies located in the United States and the United kingdom. The firm focuses on the biotechnology sector. It provides financing for early stage capital requirements. | Finance |
